New radiation strategy aims to wipe out rectal tumors in 7 out of 10 patients

NCT ID NCT07580027

First seen May 13, 2026 · Last updated May 13, 2026

Summary

This study tests a personalized radiation therapy plan for people with locally advanced rectal cancer. The goal is to increase the chance of completely eliminating the tumor before surgery from 41% to 70%. Researchers will use a special score (ERI_TCP) to select patients who may benefit most from a higher radiation dose. About 33 participants will receive this tailored treatment alongside chemotherapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • I.R.C.C.S. San Raffaele Hospital

    Milan, 20132, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.